ENTOD Pharmaceuticals partners with Infigo Eyecare to introduce advanced under-eye treatments
ENTOD Pharmaceuticals and Infigo Eyecare Hospital collaborate to enhance treatment options for under-eye pigmentation, puffiness,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India’s bio-economy can reach $ 300 bn, potentially doubling its growth from 2024
Indian Bio-Economy Report 2024 by the Association of Biotechnology Led Enterprises (ABLE) highlights India’s current bioeconomy,…
Japan aims to rejuvenate pharma landscape with new Govt fund and policy reforms: GlobalData
This new fund is part of a series of supportive steps Japan took over the past few years to enhance its pharmaceutical sector…
DKSH Technology Acquires Taqkey Science and Quantum Biotech, two technology distribution companies…
DKSH has signed an agreement to acquire Taqkey Science and Quantum Biotech in Taiwan. With these transactions, DKSH Technology…
AdjuTec Pharma, Venus Remedies initiate research collaboration to evaluate APC-148 against AMR
Venus Remedies will test APC-148 in combination with various antibiotics against its extensive library of clinical isolates…
DoP hosts industry dialogue on promotion of research and innovation in pharma-medtech sector scheme
Innovate in India and make for the world, aiming to position the country as a global leader in innovation and manufacturing for…
CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData
The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…
Leading the change: Why companies must prioritise women in management
Arushi Jain, Director, Akums Drugs and Pharmaceuticals highlights how companies that promote women to leadership positions create…
Why the best business summits are getting smaller, sharper, and smarter
Nutrify Today C-Suite SumFlex 2025 charts a new course in outcome-focused industry engagement
Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData
GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…